Impact of recurrence interval on survival of oral cavity squamous cell carcinoma patients after local relapse
- PMID: 17210345
- DOI: 10.1016/j.otohns.2006.07.002
Impact of recurrence interval on survival of oral cavity squamous cell carcinoma patients after local relapse
Abstract
Objective: The aim of this study was to investigate whether the recurrence interval influenced the survival of oral cavity squamous cell carcinoma patients after relapse.
Study design and setting: Retrospective charts were reviewed at a medical center.
Methods: We retrospectively reviewed 1687 chart records of oral cancer patients. Statistical methods included descriptive statistics, bivariate analyses, Kaplan-Meier survival analyses, and Cox proportional hazard models for investigating the relationship between the recurrence interval and survival of oral cancer patients after relapse.
Results: Local recurrence rate was 31.3 percent. Kaplan-Meier survival analyses showed the 5-year overall survival after recurrence was 31.56 percent. Cox proportional hazard model revealed that those with recurrence interval less than 18 months tended to have a higher probability of death than those with recurrence interval greater than or equal to 18 months (relative risk, 1.743; 95% confidence interval, 1.298-2.358).
Conclusion: The interval from initial treatment to recurrence is an independent prognostic factor for oral squamous cell carcinoma patients. Those with a shorter disease-free interval tend to have a less favorable outcome.
Similar articles
-
Prognostic factors in intraoral squamous cell carcinoma: the influence of histologic grade.J Oral Maxillofac Surg. 2005 Nov;63(11):1599-605. doi: 10.1016/j.joms.2005.07.011. J Oral Maxillofac Surg. 2005. PMID: 16243176
-
Biological markers and prognosis in recurrent oral cancer after salvage surgery.Arch Otolaryngol Head Neck Surg. 2008 Jul;134(7):743-9. doi: 10.1001/archotol.134.7.743. Arch Otolaryngol Head Neck Surg. 2008. PMID: 18645125
-
Socio-demographic factors in the prognosis of oral cancer patients.Oral Oncol. 2006 Oct;42(9):893-906. doi: 10.1016/j.oraloncology.2005.12.007. Epub 2006 May 26. Oral Oncol. 2006. PMID: 16730220
-
Cancer of the gingiva, buccal mucosa, and palate.J Can Dent Assoc. 1996 Feb;62(2):146-50. J Can Dent Assoc. 1996. PMID: 8820167 Review.
-
Papillary squamous cell carcinoma of the oral mucosa: a clinicopathologic and immunohistochemical study of 12 cases and literature review.Ann Diagn Pathol. 2013 Feb;17(1):18-21. doi: 10.1016/j.anndiagpath.2012.04.005. Epub 2012 Jun 4. Ann Diagn Pathol. 2013. PMID: 22672806 Review.
Cited by
-
Less Is More? The Association between Survival and Follow-Up Protocol after Treatment in Oral Cavity Cancer Patients from a Betel Quid-Prevalent Region.Int J Environ Res Public Health. 2021 Nov 29;18(23):12596. doi: 10.3390/ijerph182312596. Int J Environ Res Public Health. 2021. PMID: 34886321 Free PMC article.
-
What is the Potential Interplay between Microbiome and Tumor Microenvironment in Oral Squamous Cell Carcinomas?Asian Pac J Cancer Prev. 2022 Jul 1;23(7):2199-2213. doi: 10.31557/APJCP.2022.23.7.2199. Asian Pac J Cancer Prev. 2022. PMID: 35901324 Free PMC article. Review.
-
Recurrent Sinonasal Squamous Cell Carcinoma: Current Insights and Treatment Advances.Cancers (Basel). 2024 Dec 24;17(1):4. doi: 10.3390/cancers17010004. Cancers (Basel). 2024. PMID: 39796633 Free PMC article. Review.
-
Early relapse is an adverse prognostic factor for survival outcomes in patients with oral cavity squamous cell carcinoma: results from a nationwide registry study.BMC Cancer. 2023 Feb 7;23(1):126. doi: 10.1186/s12885-023-10602-1. BMC Cancer. 2023. PMID: 36750965 Free PMC article.
-
Cytokeratins (CK7 and CK20) Genes Expression Association with Clinicopathological Indices in Oral Squamous Cell Carcinoma and Dysplastic Oral Epithelium.Rep Biochem Mol Biol. 2021 Apr;10(1):126-134. doi: 10.52547/rbmb.10.1.126. Rep Biochem Mol Biol. 2021. PMID: 34277876 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical